BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang Y, Todd N, Thathiah A. The role of GPCRs in neurodegenerative diseases: avenues for therapeutic intervention. Current Opinion in Pharmacology 2017;32:96-110. [DOI: 10.1016/j.coph.2017.02.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 42] [Article Influence: 7.2] [Reference Citation Analysis]
Number Citing Articles
1 Huang Y, Rafael Guimarães T, Todd N, Ferguson C, Weiss KM, Stauffer FR, McDermott B, Hurtle BT, Saito T, Saido TC, MacDonald ML, Homanics GE, Thathiah A. G protein-biased GPR3 signaling ameliorates amyloid pathology in a preclinical Alzheimer's disease mouse model. Proc Natl Acad Sci U S A 2022;119:e2204828119. [PMID: 36161942 DOI: 10.1073/pnas.2204828119] [Reference Citation Analysis]
2 Chang Q, Chen S, Yang T. The GPCR Antagonistic Drug CM-20 Stimulates Mitochondrial Activity in Human RPE Cells. TOBIOCJ 2022;16:e1874091X2206270. [DOI: 10.2174/1874091x-v16-e2206270] [Reference Citation Analysis]
3 Todd NK, Huang Y, Lee JY, Doruker P, Krieger JM, Salisbury R, MacDonald M, Bahar I, Thathiah A. GPCR kinases generate an APH1A phosphorylation barcode to regulate amyloid-β generation. Cell Rep 2022;40:111110. [PMID: 35858570 DOI: 10.1016/j.celrep.2022.111110] [Reference Citation Analysis]
4 Köck Z, Ermel U, Martin J, Morgner N, Achilleas Frangakis S, Dötsch V, Hilger D, Bernhard F. Biochemical characterization of cell-free synthesized human β1 adrenergic receptor cotranslationally inserted into nanodiscs. J Mol Biol 2022;:167687. [PMID: 35717996 DOI: 10.1016/j.jmb.2022.167687] [Reference Citation Analysis]
5 Bayrak A, Hanson J, Laufer S, Pillaiyar T. Super-conserved receptors expressed in the brain: biology and medicinal chemistry efforts. Future Med Chem 2022. [PMID: 35535715 DOI: 10.4155/fmc-2022-0006] [Reference Citation Analysis]
6 Shukla R, Pahal S, Gupta A, Choudhary P, Misra K, Singh S. Modulation of GPCR receptors common to gut inflammatory diseases and neuronal disorders, Alzheimer’s and Parkinson’s diseases as druggable targets through Withania somnifera bioactives: an in silico study. Journal of Biomolecular Structure and Dynamics. [DOI: 10.1080/07391102.2022.2068072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhang B, Li S, Shui W. Post-Translational Modifications of G Protein–Coupled Receptors Revealed by Proteomics and Structural Biology. Front Chem 2022;10:843502. [DOI: 10.3389/fchem.2022.843502] [Reference Citation Analysis]
8 Zoidis G, Loza MI, Catto M. Design, Synthesis and 5-HT1A Binding Affinity of N-(3-(4-(2-Methoxyphenyl)piperazin-1-yl)propyl)tricyclo[,7]decan-1-amine and N-(3-(4-(2-Methoxyphenyl)piperazin-1-yl)propyl)-3,5-dimethyl-tricylo[,7]decan-1-amine. Molbank 2022;2022:M1353. [DOI: 10.3390/m1353] [Reference Citation Analysis]
9 Madhu MK, Debroy A, Murarka RK. Molecular Insights into Phosphorylation-Induced Allosteric Conformational Changes in a β2-Adrenergic Receptor. J Phys Chem B 2022. [PMID: 35196859 DOI: 10.1021/acs.jpcb.1c08610] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Prajapati R, Seong SH, Paudel P, Park SE, Jung HA, Choi JS. In Vitro and In Silico Characterization of Kurarinone as a Dopamine D1A Receptor Antagonist and D2L and D4 Receptor Agonist. ACS Omega 2021;6:33443-53. [PMID: 34926894 DOI: 10.1021/acsomega.1c04109] [Reference Citation Analysis]
11 Roy N, Parhar I. Habenula orphan G-protein coupled receptors in the pathophysiology of fear and anxiety. Neurosci Biobehav Rev 2021:S0149-7634(21)00501-7. [PMID: 34801259 DOI: 10.1016/j.neubiorev.2021.11.008] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Li S, Luo H, Lou R, Tian C, Miao C, Xia L, Pan C, Duan X, Dang T, Li H, Fan C, Tang P, Zhang Z, Liu Y, Li Y, Xu F, Zhang Y, Zhong G, Hu J, Shui W. Multiregional profiling of the brain transmembrane proteome uncovers novel regulators of depression. Sci Adv 2021;7:eabf0634. [PMID: 34290087 DOI: 10.1126/sciadv.abf0634] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Ochiai M, Nguyen HT, Kurihara N, Hirano M, Tajima Y, Yamada TK, Iwata H. Directly Reprogrammed Neurons as a Tool to Assess Neurotoxicity of the Contaminant 4-Hydroxy-2',3,5,5'-tetrachlorobiphenyl (4'OH-CB72) in Melon-Headed Whales. Environ Sci Technol 2021;55:8159-68. [PMID: 34061511 DOI: 10.1021/acs.est.1c01074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Bhuiyan P, Chen Y, Karim M, Dong H, Qian Y. Bidirectional communication between mast cells and the gut-brain axis in neurodegenerative diseases: Avenues for therapeutic intervention. Brain Res Bull 2021;172:61-78. [PMID: 33892083 DOI: 10.1016/j.brainresbull.2021.04.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Jeong HH, Chandrakantan A, Adler AC. Obstructive Sleep Apnea and Dementia-Common Gene Associations through Network-Based Identification of Common Driver Genes. Genes (Basel) 2021;12:542. [PMID: 33918603 DOI: 10.3390/genes12040542] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Lazim R, Suh D, Lee JW, Vu TNL, Yoon S, Choi S. Structural Characterization of Receptor-Receptor Interactions in the Allosteric Modulation of G Protein-Coupled Receptor (GPCR) Dimers. Int J Mol Sci 2021;22:3241. [PMID: 33810175 DOI: 10.3390/ijms22063241] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Nygaard M, Dowsett J, McGue M, Christensen K, Christiansen L, Tan Q, Mengel-From J. Genome-wide association analysis of cognitive function in Danish long-lived individuals. Mech Ageing Dev 2021;195:111463. [PMID: 33607172 DOI: 10.1016/j.mad.2021.111463] [Reference Citation Analysis]
18 Rani L, Mondal AC. Unravelling the role of gut microbiota in Parkinson's disease progression: Pathogenic and therapeutic implications. Neurosci Res 2021;168:100-12. [PMID: 33417973 DOI: 10.1016/j.neures.2021.01.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
19 Lavington S, Watts A. Lipid nanoparticle technologies for the study of G protein-coupled receptors in lipid environments. Biophys Rev 2020. [PMID: 33215301 DOI: 10.1007/s12551-020-00775-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
20 Sarparast M, Dattmore D, Alan J, Lee KSS. Cytochrome P450 Metabolism of Polyunsaturated Fatty Acids and Neurodegeneration. Nutrients 2020;12:E3523. [PMID: 33207662 DOI: 10.3390/nu12113523] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
21 Naz F, Arish M. GPCRs as an emerging host-directed therapeutic target against mycobacterial infection: From notion to reality. Br J Pharmacol 2020. [PMID: 33150959 DOI: 10.1111/bph.15315] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Li X, Xie L, Qu X, Zhao B, Fu W, Wu B, Wu J. GPR91, a critical signaling mechanism in modulating pathophysiologic processes in chronic illnesses. FASEB J 2020;34:13091-105. [PMID: 32812686 DOI: 10.1096/fj.202001037R] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
23 Lu K, Yang K, Niyongabo E, Shu Z, Wang J, Chang K, Zou Q, Jiang J, Jia C, Liu B, Zhou X. Integrated network analysis of symptom clusters across disease conditions. J Biomed Inform 2020;107:103482. [PMID: 32535270 DOI: 10.1016/j.jbi.2020.103482] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
24 Patzke C, Brockmann MM, Dai J, Gan KJ, Grauel MK, Fenske P, Liu Y, Acuna C, Rosenmund C, Südhof TC. Neuromodulator Signaling Bidirectionally Controls Vesicle Numbers in Human Synapses. Cell 2019;179:498-513.e22. [PMID: 31585084 DOI: 10.1016/j.cell.2019.09.011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 11.5] [Reference Citation Analysis]
25 Azam S, Haque ME, Jakaria M, Jo SH, Kim IS, Choi DK. G-Protein-Coupled Receptors in CNS: A Potential Therapeutic Target for Intervention in Neurodegenerative Disorders and Associated Cognitive Deficits. Cells 2020;9:E506. [PMID: 32102186 DOI: 10.3390/cells9020506] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
26 Lou R, Tang P, Ding K, Li S, Tian C, Li Y, Zhao S, Zhang Y, Shui W. Hybrid Spectral Library Combining DIA-MS Data and a Targeted Virtual Library Substantially Deepens the Proteome Coverage. iScience 2020;23:100903. [PMID: 32109675 DOI: 10.1016/j.isci.2020.100903] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
27 Isawi IH, Morales P, Sotudeh N, Hurst DP, Lynch DL, Reggio PH. GPR6 Structural Insights: Homology Model Construction and Docking Studies. Molecules 2020;25:E725. [PMID: 32046081 DOI: 10.3390/molecules25030725] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Mulindwa J, Matovu E, Enyaru J, Clayton C. Blood signatures for second stage human African trypanosomiasis: a transcriptomic approach. BMC Med Genomics 2020;13:14. [PMID: 32000760 DOI: 10.1186/s12920-020-0666-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
29 Golay H, Jurkovic Mlakar S, Mlakar V, Nava T, Ansari M. The Biological and Clinical Relevance of G Protein-Coupled Receptors to the Outcomes of Hematopoietic Stem Cell Transplantation: A Systematized Review. Int J Mol Sci 2019;20:E3889. [PMID: 31404983 DOI: 10.3390/ijms20163889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
30 Wouters E, Vasudevan L, Crans RAJ, Saini DK, Stove CP. Luminescence- and Fluorescence-Based Complementation Assays to Screen for GPCR Oligomerization: Current State of the Art. Int J Mol Sci 2019;20:E2958. [PMID: 31213021 DOI: 10.3390/ijms20122958] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
31 Grimm MO, Lauer AA, Grösgen S, Thiel A, Lehmann J, Winkler J, Janitschke D, Herr C, Beisswenger C, Bals R, Grimm HS, Hartmann T. Profiling of Alzheimer’s disease related genes in mild to moderate vitamin D hypovitaminosis. The Journal of Nutritional Biochemistry 2019;67:123-37. [DOI: 10.1016/j.jnutbio.2019.01.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
32 Doijen J, Van Loy T, Landuyt B, Luyten W, Schols D, Schoofs L. Advantages and shortcomings of cell-based electrical impedance measurements as a GPCR drug discovery tool. Biosens Bioelectron. 2019;137:33-44. [PMID: 31077988 DOI: 10.1016/j.bios.2019.04.041] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
33 de Oliveira PG, Ramos MLS, Amaro AJ, Dias RA, Vieira SI. Gi/o-Protein Coupled Receptors in the Aging Brain. Front Aging Neurosci 2019;11:89. [PMID: 31105551 DOI: 10.3389/fnagi.2019.00089] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
34 Farfán-García ED, Márquez-Gómez R, Barrón-González M, Pérez-Capistran T, Rosales-Hernández MC, Pinto-Almazán R, Soriano-Ursúa MA. Monoamines and their Derivatives on GPCRs: Potential Therapy for Alzheimer's Disease. Curr Alzheimer Res 2019;16:871-94. [PMID: 30963972 DOI: 10.2174/1570159X17666190409144558] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
35 Jones L, Kumar J, Mistry A, Sankar Chittoor Mana T, Perry G, Reddy VP, Obrenovich M. The Transformative Possibilities of the Microbiota and Mycobiota for Health, Disease, Aging, and Technological Innovation. Biomedicines 2019;7:E24. [PMID: 30925795 DOI: 10.3390/biomedicines7020024] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
36 De Groof TW, Bobkov V, Heukers R, Smit MJ. Nanobodies: New avenues for imaging, stabilizing and modulating GPCRs. Molecular and Cellular Endocrinology 2019;484:15-24. [DOI: 10.1016/j.mce.2019.01.021] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
37 Hendrickx JO, van Gastel J, Leysen H, Santos-Otte P, Premont RT, Martin B, Maudsley S. GRK5 - A Functional Bridge Between Cardiovascular and Neurodegenerative Disorders. Front Pharmacol 2018;9:1484. [PMID: 30618771 DOI: 10.3389/fphar.2018.01484] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
38 Sapra KT, Spoerri PM, Engel A, Alsteens D, Müller DJ. Seeing and sensing single G protein-coupled receptors by atomic force microscopy. Curr Opin Cell Biol 2019;57:25-32. [PMID: 30412846 DOI: 10.1016/j.ceb.2018.10.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
39 Haque ME, Kim IS, Jakaria M, Akther M, Choi DK. Importance of GPCR-Mediated Microglial Activation in Alzheimer's Disease. Front Cell Neurosci 2018;12:258. [PMID: 30186116 DOI: 10.3389/fncel.2018.00258] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
40 Boland B, Yu WH, Corti O, Mollereau B, Henriques A, Bezard E, Pastores GM, Rubinsztein DC, Nixon RA, Duchen MR, Mallucci GR, Kroemer G, Levine B, Eskelinen EL, Mochel F, Spedding M, Louis C, Martin OR, Millan MJ. Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing. Nat Rev Drug Discov 2018;17:660-88. [PMID: 30116051 DOI: 10.1038/nrd.2018.109] [Cited by in Crossref: 183] [Cited by in F6Publishing: 224] [Article Influence: 45.8] [Reference Citation Analysis]
41 Moreno E, Canet J, Gracia E, Lluís C, Mallol J, Canela EI, Cortés A, Casadó V. Molecular Evidence of Adenosine Deaminase Linking Adenosine A2A Receptor and CD26 Proteins. Front Pharmacol 2018;9:106. [PMID: 29497379 DOI: 10.3389/fphar.2018.00106] [Cited by in Crossref: 27] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
42 Myeku N, Duff KE. Targeting the 26S Proteasome To Protect Against Proteotoxic Diseases. Trends Mol Med 2018;24:18-29. [PMID: 29233753 DOI: 10.1016/j.molmed.2017.11.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
43 Hayashi K, Yamashita R, Takami R, Matsui T, Gotou M, Nishimoto T, Kobayashi H. Strategy for Identification of Phosphorylation Levels of Low Abundance Proteins in Vivo for Which Antibodies Are not Available. J Cardiovasc Dev Dis 2017;4:E17. [PMID: 29367546 DOI: 10.3390/jcdd4040017] [Reference Citation Analysis]